Eur Heart J Cardiovasc Pharmacother
January 2019
Aims: Guidelines concerning β-blocker treatment following acute myocardial infarction (AMI) are based on studies undertaken before the implementation of reperfusion and secondary prevention therapies. We aimed to estimate the effect of oral β-blockers on mortality in contemporary post-AMI patients with low prevalence of heart failure and/or reduced left ventricular ejection fraction.
Methods And Results: A random effects model was used to synthetize results of 16 observational studies published between 1 January 2000 and 30 October 2017.